Cristian Alejandro Castillo Rodríguez

Dr. Cristian Alejandro Castillo Rodríguez

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MJMichel Juarez
Michel Juarez
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
DSDina Soliman
Dina Soliman
GRGaspar Del Rio-Pertuz
Gaspar Del Rio-Pertuz
Kenneth NugentKenneth Nugent
Kenneth Nugent
Cardiopulmonary exercise testing (CPET) provides important information for the assessment and management of patients with heart failure. This testing measures the respiratory and cardiac responses to exercise and allows measurement of the oxygen uptake (V˙O2) max and the relationship between minute ventilation (V˙E) and carbon dioxide excretion (V˙CO2). These two parameters help classify patients into categories that help predict prognosis, and patients with a V˙O2 < 14 mL/kg/min and V˙E/V˙CO2 slope >35 have a poor prognosis. This testing has been used in drug trials to determine complex physiologic responses to medications, such as angiotensin-converting enzyme inhibitors. For example, a study with enalapril demonstrated that the peak V˙O2 was 14.6 ± 1.6 mL/kg/min on placebo and 15.8 ± 2.0 mL/kg/min on enalapril after 15 days of treatment. The V˙E/V˙CO2 slopes were 43 ± 8 on placebo and 39 ± 7 on enalapril. Chronic heart failure and reduced physical activity measured by cardiopulmonary exercise testing are associated with increases in BNP, and several studies have demonstrated that cardiac rehabilitation is associated with reductions in BNP and increases in V˙O2. Therefore, BNP measurements can help determine the benefits of cardiac rehabilitation and provide indirect estimates of changes in V˙O2. In addition, measurement of microRNAs can determine the status of skeletal muscle used during physical activity and the changes associated with rehabilitation. However, CPET requires complicated technology, and simpler methods to measure physical activity could help clinicians to manage their patients. Recent advances in technology have led to the development of portable cardiopulmonary exercise testing equipment, which can be used in various routine physical activities, such as walking upstairs, sweeping the floor, and making the bed, to provide patients and clinicians a better understanding of the patient’s current symptoms. Finally, current smart watches can provide important information about the cardiorespiratory system, identify unexpected clinical problems, and help monitor the response to treatment. The organized use of these devices could contribute to the management of certain aspects of these patients’ care, such as monitoring the treatment of atrial fibrillation. This review article provides a comprehensive overview of the current use of CPET in heart failure patients and discusses exercise principles, methods, clinical applications, and prognostic implications.

22 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJuthipong Benjanuwattra
Juthipong Benjanuwattra
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
MAMahmoud Abdelnabi
Mahmoud Abdelnabi
RIRamzi Ibrahim
Ramzi Ibrahim
HPHoang Nhat Pham
Hoang Nhat Pham
RAReza Arsanjani
Reza Arsanjani
Coronary artery disease (CAD) remains the leading cause of cardiovascular morbidity and mortality worldwide, with plaque composition and morphology being as key determinants of disease progression and clinical outcomes. Accurate plaque characterization is essential for risk stratification and therapeutic decision-making, yet conventional image interpretation is limited by inter-observer variability and time-intensive workflows. Artificial intelligence (AI) models have emerged as a transformative tool for automated coronary plaque analysis across multiple imaging modalities. AI-driven models demonstrate high diagnostic accuracy for plaque detection, segmentation, quantification, and vulnerability assessment. Integration of AI-derived imaging biomarkers with clinical risk scores can further enhance prediction of major adverse cardiovascular events and supports personalized management. These advances position AI-enhanced imaging as a powerful adjunct for both invasive and non-invasive evaluation of CAD. Despite its promise, important barriers to widespread clinical adoption remain, including data heterogeneity, algorithmic bias, limited model transparency, insufficient prospective validation, regulatory challenges, and incomplete integration into clinical workflows. Addressing these challenges will be essential to ensure safe, generalizable, and cost-effective implementation of AI in routine cardiovascular care.

12 October 2022 in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
Verified
Journal Article
Open access
PDF file
SUSebastian Felipe Sierra Umaña
Sebastian Felipe Sierra Umaña
AAAndrés Garcés Arias
Andrés Garcés Arias
SMSebastian Salinas Mendoza
Sebastian Salinas Mendoza
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
JGJuan Pablo Alzate Granados
Juan Pablo Alzate Granados
Contexto: Factores dietarios poco saludables se han asociado con aumento de riesgo cardiovascular, uno de ellos; consumo de azúcar. Objetivo: Búsqueda, evaluación y análisis de la mejor evidencia disponible sobre el consumo de azúcar y desenlaces mayores cardiovasculares. Metodología: Revisión sistemática de la literatura. Evaluación cuantitativa entre consumo de azúcar y alguno de los siguientes eventos cardiovasculares mayores (muerte cardiovascular, infarto agudo de miocardio no fatal o accidente cerebrovascular no fatal). Se incluyeron participantes mayores de 18 años no gestantes, sin cardiopatía congénita. Resultados: Se incluyeron 31 estudios primarios (27 estudios de cohortes y 4 estudios de casos y controles). Veintiuno evaluaron el consumo de azúcar e infarto agudo de miocardio, 12 consumo de azúcar y accidente cerebrovascular y 6 consumo de azúcar y muerte cardiovascular. Para los 3 desenlaces los resultados fueron controversiales, sin embargo, con significancia estadística en varios estudios para la asociación en cuestión, al evaluarse el consumo de azúcar por carga glucémica, índice glucémico, carbohidratos totales, entre otros. Conclusiones: Sin bien la evidencia es contradictoria, sugiere de forma consistente a partir de estudios de cohorte que los carbohidratos con alto índice glucémico, azucares añadidos y bebidas azucaradas, aumentan el riesgo de presentar eventos adversos cardiovasculares mayores como infarto agudo de miocardio, ataque cerebrovascular y muerte cardiovascular.

3 August 2025 in Clinical Case Reports
Verified
Journal Article
Open access
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
DSDina Soliman
Dina Soliman
MJMichel Juarez
Michel Juarez
SRSherif Roman
Sherif Roman
JAJohn Abdelmalek
John Abdelmalek
VTVictor Test
Victor Test
Platypnea‐orthodeoxia syndrome is a rare disorder characterized by dyspnea (platypnea) and arterial desaturation (orthodeoxia) in the upright position, with symptom relief upon lying down. This syndrome is commonly associated with cardiac anomalies, particularly patent foramen ovale (PFO), where increased right atrial pressure facilitates right‐to‐left shunting, leading to hypoxemia. Other associated conditions include cirrhosis, pericardial effusion, and pneumonectomy. We present a 32‐year‐old female with a history of right pneumonectomy for invasive aspergillosis who presented with worsening dyspnea and a greater than 10% drop in SpO2 when seated compared to the supine position. Initial imaging demonstrated rightward displacement of thoracic structures, including the right atrium, but a transthoracic echocardiogram was negative for intracardiac shunt. Due to persistent hypoxemia, a transesophageal echocardiogram was performed, revealing a right‐to‐left shunt, an atrial septal aneurysm, and a prominent Eustachian valve. The patient underwent successful PFO closure, leading to the complete resolution of both dyspnea and hypoxemia. This case emphasizes the importance of comprehensive diagnostic evaluation in patients with POS, especially those with complex cardiopulmonary histories.

1 October 2026 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
CPChanokporn Puchongmart
Chanokporn Puchongmart
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
DSDina Soliman
Dina Soliman
VSVarote Shotelersuk
Varote Shotelersuk
NSNithila Sivakumar
Nithila Sivakumar
ZSZhaunn Sly
Zhaunn Sly
Type 2 myocardial infarction (T2MI) results from myocardial oxygen supply–demand imbalance in the absence of acute atherothrombotic plaque rupture and is associated with substantial short-term and long-term mortality. Although increasingly recognized with the widespread use of high-sensitivity cardiac troponin assays, optimal pharmacologic management of T2MI remains poorly defined. We performed a narrative review evaluating pharmacologic treatment patterns and outcomes in adults with adjudicated or clinically coded T2MI. Evidence consistently demonstrates a high prevalence of underlying coronary artery disease in T2MI, with up to two-thirds of patients exhibiting significant coronary artery stenosis. Despite this overlap with ischemic heart disease, prescription rates of antiplatelet agents, statins, β-blockers, and renin–angiotensin–aldosterone system inhibitors are substantially lower in T2MI compared with type 1 myocardial infarction. Observational data suggest that statins, β-blockers, renin–angiotensin–aldosterone system inhibitors, and combination secondary prevention strategies may be associated with improved survival, whereas evidence supporting routine antiplatelet or anticoagulant therapy remains limited and inconsistent. Overall, T2MI represents a high-risk and underrecognized clinical entity for which pharmacologic management is largely extrapolated from type 1 myocardial infarction and coronary artery disease. Prospective, T2MI-focused studies are urgently needed to define optimal secondary prevention strategies and improve clinical outcomes.

19 March 2025
Verified
Preprint
Open access
CRCristian Alejandro Castillo Rodríguez
Cristian Alejandro Castillo Rodríguez
CPChanokporn Puchongmart
Chanokporn Puchongmart
BTBen Thiravetyan
Ben Thiravetyan
TYThanaboon Yinadsawaphan
Thanaboon Yinadsawaphan
CWChalothorn Wannaphut
Chalothorn Wannaphut
NKNarathorn Kulthamrongsri
Narathorn Kulthamrongsri